Pasadena Private Wealth’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-12,271
Closed -$229K – 283
2025
Q3
$229K Sell
12,271
-1,414
-10% -$26.4K 0.03% 183
2025
Q2
$252K Sell
13,685
-731
-5% -$13K 0.04% 160
2025
Q1
$252K Buy
14,416
+218
+2% +$3.68K 0.05% 156
2024
Q4
$246K Buy
14,198
+180
+1% +$3.29K 0.05% 129
2024
Q3
$261K Sell
14,018
-1,957
-12% -$33K 0.06% 121
2024
Q2
$246K Sell
15,975
-5,090
-24% -$72.7K 0.06% 123
2024
Q1
$311K Sell
21,065
-286
-1% -$3.96K 0.07% 103
2023
Q4
$305K Buy
+21,351
New +$303K 0.07% 108

Other funds holding SBRA

Pasadena Private Wealth's SBRA Position: Q4 2025 in Review

Pasadena Private Wealth sold out of Sabra Healthcare REIT (SBRA) in Q4 2025, closing a stake of 12,271 shares — an estimated $229K sold.

Pasadena Private Wealth first reported a position in SBRA in Q4 2023 and held it in 8 quarters. The position peaked at $311K in Q1 2024. 441 funds tracked by Wall St. Rank hold SBRA as of Q4 2025.

  • Pasadena Private Wealth reported no remaining Sabra Healthcare REIT position as of Q4 2025 after selling out during the quarter.
  • Pasadena Private Wealth sold 12,271 Sabra Healthcare REIT shares in Q4 2025, an estimated $229K.
  • Pasadena Private Wealth first reported a position in Sabra Healthcare REIT in Q4 2023 and held it in 8 quarters.
  • Pasadena Private Wealth's Sabra Healthcare REIT position peaked at $311K in Q1 2024.
  • 441 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q4 2025.

Based on Pasadena Private Wealth's 13F filing for Q4 2025, filed 10 Feb 2026.